Cholera toxin added into cell cultures together with human leukocyte interferon inhibited the establishment of the antiviral state by interferon but not the anticellular activity of interferon in human cells. Sensitivities of various human cell lines to anticellular activities of interferon and cholera toxin were compared, but no direct correlation between both activities were demonstrated. These results suggest that antiviral and anticellular activities of interferon are due to different mechanism of actions, and cholera toxin does not act directly on the receptor site for interferon.
Several kinds of data show that interferon binds to the surface of cells and a variety of biological effects are subsequently induced in those cells (6, 14) . Interferon treatment results in modification of the cell surface (7) . The binding of cholera toxin or thyrotropin (TSH) to plasma membrane can be altered by interferon treatment of cells (22) . Interferon also reduces the sensitivity of cells to diphtheria toxin (29) . Recently, data from our laboratory showed interferon inhibits syncytia formation by RD-114 virus (31) . Friedman and Kohn (9) , on the other hand, reported that cholera toxin inhibits the development of an antiviral state by interferon. The action of interferon at the cell surface resembles in many respects the action of cholera toxin. Cholera toxin stimulates adenyl cyclase and increases the complementary adenosine 5'-monophosphate (cAMP) level followed by inhibition of deoxyribonucleic acid (DNA) synthesis and cell division (15, 17) . Interferon also elevates cellular cAMP levels, which is associated with the development of an antiviral state (28, 34) and the inhibition of DNA synthesis (13) . Other lines of data have shown that receptors for cholera toxin and interferon seem to consist of gangliosides or ganglioside-like structure, e.g., cholera toxin binds to galactosyl-N-acetylgalactosaminyl-(N-acetylneuraminyl)-galactosylglucosylceramide (GM1) (32) , mouse interferon binds to N-acetylgalactosaminyl-(N-acetylneuraminyl) -galactosylglucosylceramide (GM2) and Nacetylneuraminylgalactosyl-N-acetylgalactosaminyl -(N -acetylneuraminyl-N-acetylneuraminyl)-galactosylglucosylceramide (GT1) (1, 2) , and human interferon binds to GM1, GM2 (33) , and N-acetylneuraminylgalactosylglucosylceramide (GM3) (26) . However, whether cholera toxin acts at the same receptor site or elsewhere but very near the site as interferon is not clear. There also exists the possibility that the interaction of cholera toxin and receptor induces the secondary changes in the membrane, which results in inhibition of interferon action. In this paper we report the effect of cholera toxin on antiviral and anticellular activities of human leukocyte interferon.
MATERIALS AND METHODS
Cell and cultures. RSa cells were obtained from double-transformed foci induced by Rous sarcoma virus and simian virus 40 in human embryonic fibroblasts (27) After 1 h of incubation cells were washed three times with cold phosphate-buffered saline (pH 7.6) and lysed by adding 0.5 ml of 0.5% sodium dodecyl sulfate solutions. Then 0.5 ml of 20% trichloroacetic acid solutions were added to each well. The trichloroacetic acidinsoluble materials were collected onto Whatman GF/ C filters by filtration. The radioactivities of trichloroacetic acid-insoluble materials were measured as previously described (11, 12) .
Radioimmunoassay for cAMP. The content of cAMP in cells was measured by the radioimmunoassay method (13, 16) by using a Yamasa cAMP assay kit (Yamasa Shouyu Co., Ltd., Choshi, Japan).
RESULTS
Effect of cholera toxin on antiviral activity of human leukocyte interferon. Human leukocyte interferon was applied to RSa cell Effect of cholera toxin on anticellular activity of human leukocyte interferon. In addition to antiviral activity interferon has an anticellular activity. We also investigated the effect of cholera toxin on this activity. reduced the amount of [:iH]thyiidine incorporated into acid-precipitable materials of RSa cells to 78 and 55%, respectively (Fig. 1) . Cholera toxin at a low concentration which slightly inhibits DNA synthesis has little or no effect on anticellular action of interferon, but at a high concentration it reduces DNA synthesis additively. A similar result was obtained with IFr-V1 cells (Fig. 2) . When cells were treated with interferon and cholera toxin for 6 days and the cell number was counted, similar results were obtained in terms of cell growth (data not shown).
Sensitivities of various human cell lines to anticellular activities of interferon and cholera toxin. Inhibition of DNA synthesis in various human cells was compared with respect to dose response relationship after exposure to interferon and cholera toxin. Each cell line responded differently to interferon and cholera toxin ( Fig. 3a and b) . RSa cells were the most sensitive cells to anticellular activity of interferon, with less than 100 U of interferon per ml being sufficient to reduce DNA synthesis after 2 days of incubation. VA-13 cells required 300 U of interferon per ml for a 50% reduction. IFr were more resistant than IFr-V1, VA-13, and HEL/K cells were to cholera toxin. We measured cAMP levels of cells 3 h after cholera toxin treatment to see the more direct response of cells to cholera toxin. Similar results were obtained as determined by inhibition of DNA synthesis (Table 2) . Thus, no correlation could be demonstrated between the sensitivities of cells to anticellular activity of human leukocyte interferon and cholera toxin. DISCUSSION Results from this investigation show that cholera toxin added together with human leukocyte interferon inhibited the establishment of the antiviral state in human cells as in the case of mouse interferon and the mouse cell system reported by Friedman et al. (9) . Before production of biological effects, the cholera toxin-receptor complex redistributes on the plane of the membrane (3). Adenyl cyclase activation by cholera toxin is also viewed as occurring in three stages (35) . Therefore, it is considered that a change in the state of the membrane occurs after the cholera toxin-receptor interaction. In fact, VOL. 26, 1979 237 with GM2 and GT1 (1, 2) and human interferon is neutralized by several kinds of gangliosides, including GM1 (33) .
(ii) Interferon has relatively high species specificity, but cholera toxin has very low specificity, e.g., human and mouse interferon do not cross-react with each heterologous cell, but cholera toxin reacts with both human and mouse cells. In contrast to the inhibitory effect on antiviral activity of interferon, cholera toxin had little or no inhibitory effect on the anticellular activity of interferon ( Fig. 1 and 2) . Exertion of biological activities of interferon does not appear to lie solely at the initial point of binding to the cell surface because mouse interferon is shown to bind to plasma membrane of human KB-3 cells but does not induce an increase in cAMP levels and a development of an antiviral state (28) . Kohn (21) suggests that the glycoprotein component may be the primary binding site and the ganglioside may be the discriminator and coupler for TSH. In the interferon-KB-3 cell system, these cells bind interferon, TSH, and cholera toxin in the presence of an apparently normal glycoprotein receptor component; message transmission is, however, blocked in the absence or near absence of appropriate gangliosides (8, 21) . One possible explanation of our results is that a change in the state of membrane by cholera toxin resulted in no transmission of an antiviral message of interferon, although interferon could bind to receptor, but the interferonreceptor complex allowed to transmit its anticellular message to the cell membrane.
There were several reports which also showed a dissociation of antiviral and non-antiviral effect of interferon. Some cell lines exhibited the differences in sensitivity to antiviral and anticellular activities of interferon (10, 23) . Our previous reports showed that antiviral activity was inhibited by ouabain (24) , puromycin, and cycloheximide (25) , but anticellular activity was not. In contrast, Kading et al. (19) reported that fetal bovine serum prevented the inhibitory effect of mouse interferon on clone formation but did not affect the antiviral activity. De Clercq et al. (5) found that antiviral activity of human interferon was genetically determined by chromosome 21, but the non-antiviral activities were not. Dahl and Degre (4) have reported that the growth inhibitory fraction of human interferon could be separated from antiviral activity, but in most recent investigations (18, 20) there was a quantitative correlation between the antiviral activity of given fractions which were purified at different degrees and its anticellular activity. Therefore, the present data do not necessarily mean that the antiviral and the anticellular activities are due to different molecules, but that both activities are due to different mechanisms of action. To confirm this concept, it would be necessary to clarify the nature of the molecular mechanism by which interferon exerts its anticellular activity.
